Generic Name: FLUTICASONE HFA INHALER - ORAL Pronounced: (floo-TIK-a-sone) Flovent HFA Inhl Uses
Fluticasone is used to control and prevent symptoms (such
as wheezing and shortness of breath) caused by asthma. It works by reducing
swelling (inflammation) of the airways in the lungs to make breathing easier.
Controlling symptoms of asthma helps you maintain your normal activities and
decreases time lost from work or school. Fluticasone belongs to a class of
drugs known as corticosteroids.
This medication must be used regularly to be effective. It
does not work immediately and should not be used to relieve sudden asthma
attacks. If an asthma attack occurs, use your quick-relief inhaler (such as
albuterol, also called salbutamol in some countries) as
How To Use Flovent HFA Inhl
Read the Patient Information Leaflet that comes with this
product before you start using fluticasone and each time you get a refill. Read
Chronic obstructive pulmonary disease (COPD), also called chronic obstructive lung disease , is a term that is used for two closely related diseases of the respiratory system: chronic bronchitis and emphysema . In many cases these diseases occur together, although there may be more symptoms of one than the other. Most patients with these diseases have a long history of heavy cigarette smoking. COPD gets gradually worse over time. At first, there may be only a mild shortness of breath and occasional coughing. Then a chronic cough develops with clear, colorless sputum. As the disease progresses, the cough becomes more frequent and more effort is needed to get air into and out of the lungs. In later stages of the disease, the heart may be affected. Eventually death occurs when the function of the lungs and heart is no longer adequate to deliver oxygen to the body's organs and tissues. COPD often develops in people at the height of their productive years, disabling them with constant shortne...
The phrase "reactive airways dysfunction syndrome" (RADS) denotes the development of a persistent asthma -like condition with airway hyper-responsiveness developing in a previously healthy asymptomatic individual within 24 hours of a single exposure to concentrated respiratory irritants. Not all experts are certain that RADS and a close counterpart, irritant-induced asthma (IIA), are real clinical entities. Recently, a state-of-the-art review concluded with some reservation that airway-hyper-responsiveness may be acquired as a result of non-immunogenic irritant exposures. Yet no published article on RADS or IIA has provided measurements of airway responsiveness obtained before an incriminated exposure incident, and none has quantified the intensity of the exposures. Taken in its entirety, the current scientific evidence supports the conclusion that RAD and IIA are valid clinical disorders. Respiratory irritants can lead to asthma and rhinitis through interaction with chemical ir...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.